ArticleMolecular cancer therapeutics2013

VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.

Stefan Hart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.